Streamex (STEX) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Streamex

NasdaqCM•Financial Services•Capital Markets

$0.71-0.01(-0.01%)Pre-market

Market Cap

$110.48M

P/S

694.9x

P/B

0.8x

Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.

How this company scores

WeakMetricSide Score: 34/100

Strongest: Balance Sheet & Red Flags (15/25); weakest: Cash & Earnings Quality (2/25).

Profitability3/25

Growth14/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality2/25

Strengths

Growing revenueInterest easily coveredNet cash positionImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 694.9x5y range 93.9x – 7418.5x

Currently above its 20-quarter median.

P/B · 0.8x5y range 0.8x – 616.5x

Currently below its 13-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $110.48M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $159,000
Q. Revenue: $146,000
TTM EBITDA: $-98.57M
TTM Op. Income: $-98.65M
Q. Op. Income: $-15.16M
TTM Net Income: $-500.84M
Q. Net Income: $-14.55M
EPS: $-0.08
Shares Out.: $182.02M

$159,000 in TTM revenue grew 297.5% YoY, reaching $146,000 last quarter. TTM EBITDA of $-98.57M and TTM operating income of $-98.65M show growth is flowing through to the bottom line. However, net income is negative at $500.84M — growth is not yet reaching the bottom line. Over the past year, TTM revenue is up 298% — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: -10380.8%
Op. Margin: -10384.2%
Net Margin: -9967.1%

Op. margin of -10384.2% is up 146269.6% YoY — cost efficiency is improving. Net margin at -9967.1% Over the past year, operating margin is up 93% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 694.9x
P/B Ratio: 0.8x

P/S of 694.9x and P/B of 0.8x. P/S is high, meaning growth expectations are priced in.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $159.58M
Cash: $5.61M
Long-Term Debt: N/A
Book Value: $147.11M
D/E Ratio: N/A
Debt/EBITDA: N/A

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-11.74M
TTM Free Cash Flow: $-29.96M
FCF Margin: -18844.0%
FCF / Net Income: 0.1

TTM FCF of $-29.96M on $-11.74M in operating cash flow. The FCF / Net Income ratio of 0.1x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has fallen for 4 consecutive quarters — a weakening trend.